Hormone therapy in perimenopause: a clear, honest guide

Why perimenopause changes the rules — and the treatment

Perimenopause is not a gentle, downhill slope. Estrogen doesn't fade in a straight line; it swings, sometimes higher than before, then drops. That is why the symptoms can feel so erratic, and why they are often at their worst in the years before your final period, not after.

It also changes how treatment works. Because you're still cycling, hormone therapy in perimenopause is usually given as a sequence that works with your remaining rhythm, rather than the steady, continuous dose used once periods have stopped for good. Same medicine, different choreography.

What hormone therapy actually does — and what it doesn't

It is the most effective treatment there is for hot flashes, night sweats, and vaginal dryness, and it protects your bones from the thinning that accelerates around menopause. For many women, the first real night of sleep in months is the moment it stops being abstract.

It is not a cure for everything midlife throws at you. It treats the symptoms driven by falling estrogen. It is not a weight-loss drug, and it won't fix problems that were never hormonal. Knowing that boundary is part of choosing well.

"Is it too early?" The window that matters

This is the question that holds the most women back, and the answer is usually no. You don't have to wait until your periods stop to deserve treatment. The symptoms are frequently worst during perimenopause, and waiting until you're "officially" menopausal to treat them is, for many women, waiting too long.

There is a timing principle worth knowing, sometimes called the window of opportunity: for most healthy women, starting hormone therapy under age 60, or within ten years of menopause, is when the benefits most clearly outweigh the risks. Starting much later carries more risk. Perimenopause sits comfortably inside that window.

Patch, pill, or gel — and why it changes your risk

How you take estrogen matters as much as whether you take it. Swallowed as a pill, it passes through the liver, which slightly raises the risk of blood clots and stroke. Absorbed through the skin as a patch or gel, it skips that first pass, and that route carries a lower clot risk.

For many women, especially those with any clotting concern, transdermal estrogen at a low dose is the safer starting point. It is exactly the kind of detail a good prescriber will raise — and a thin one will not.

Bioidentical, compounded, FDA-approved: cutting through the words

"Bioidentical" simply means the hormone is structurally identical to the one your body makes. That sounds reassuring, and it can be — but the word has been blurred by marketing. The important distinction is regulation, not the label.

FDA-approved bioidentical hormones exist, are well-studied, and come in standardized doses. Custom-compounded hormones, mixed to order and sold by some clinics as a premium option, are a different matter. The Menopause Society does not recommend them: they are not better regulated, and they have not been shown to be safer or more effective than the approved versions. If a provider leans hard on "custom" compounding as their selling point, that is a fair question to ask them about.

What about breast cancer? And weight?

The breast-cancer question deserves a straight answer, not a scare and not a brush-off. For estrogen-plus-progestogen therapy, a small increase in risk appears after about three to five years of use. Estrogen alone carries a longer runway. In the large Women's Health Initiative study, combined therapy meant roughly three to four extra cases per 1,000 women over five years — real, but small, and something most experts weigh against a meaningful gain in quality of life.

On weight: the changes many women see in their forties track with shifting hormones and metabolism, not with hormone therapy itself. If weight is your main concern, that is a different conversation — we walk through it in our guide on GLP-1 medications for menopause weight gain.

Periods, bleeding, and contraception — the part no one explains

Here is what gets left out. Because you're still having periods, a continuous dose started too early can cause unpredictable bleeding, so a sequential regimen is used instead, often giving you a regular monthly withdrawal bleed. And hormone therapy is not contraception — you can still get pregnant in perimenopause.

There is an elegant solution many women aren't told about: a hormonal IUD, such as Mirena, can supply the progestogen part of your hormone therapy and act as contraception at the same time. One device, two jobs.

You probably don't need a blood test

If a clinic insists on an expensive hormone panel before they'll help, be a little wary. ACOG is clear that perimenopause is diagnosed from your age, your symptoms, and the changes in your cycle — not from a blood test. Hormone levels zig-zag from day to day, so a single reading can easily mislead.

Testing has its place, mainly to rule out other explanations like thyroid problems, or when symptoms arrive young, before 45. But for the typical woman in her late forties with classic symptoms, the diagnosis is the story you tell, not the number on a lab slip.